There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago. But the Absorb stent was not able to match the performance or outcomes of the ...
Stents Bare Metal
Bare metal stents are mesh-like tubes of thin wire without a coating or covering. Ideally, bare metal stents will be covered by a new layer of endothelial cells, sealing it into the vessel wall, within a few weeks after implant. However, a percentage of patients have their body negatively respond to the implanted foreign body, resulting in the formation of neointimal hyperplasia, a growth of scar tissue over the stent. This can cause restenosis of the vessel segment, which led to the development of drug-eluting stents (DES) now used in most patients. However, DES require the patient to take long-term antiplatelet medication, so patients who are likely to be noncompliant are often given bare metal stents.
-
-
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug Administration (FDA) approval utilizing results from the BIOHELIX-I clinical study. This stent, which has already been used to treat more than 650,000 patients worldwide, is now available in the United States.
-
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel platinum chromium coronary stent system, the company's latest-generation bare-metal stent for the treatment of coronary artery disease (CAD).
-
A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare metal stent in true bifurcation coronary lesions found that that the strategy was safe, but the results did not establish non-inferiority compared to the currently accepted strategy of using a single stent with provisional use of a second side branch stent when indicated.
There was a lot of hype and high hopes pinned on bioresorbable stent technologies as the way of the future two years ago ...
January 29, 2019
December 14, 2017 — The U.S. Food and Drug Administration (FDA) announced clearance for NuMed’s Cheatham Platinum (CP) S ...
December 14, 2017
November 10, 2017 — Cordis, a Cardinal Health company, recently unveiled a comprehensive interventional cardiology portf ...
November 10, 2017
September 22, 2017 — Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy ...
September 22, 2017
February 15, 2017 — The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S ...
February 15, 2017
December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-Expanding ...
December 31, 2015December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the ...
December 09, 2015June 11, 2015 - Patients who received a bare metal coronary stent did not display significant differences in rates of ...
June 11, 2015
July 22, 2014 — Boston Scientific announced it received U.S. Food and Drug Administration (FDA) approval for the Rebel ...
July 22, 2014
March 13, 2014 — Boston Scientific Corp. received CE marking for the Rebel Platinum Chromium Coronary Stent System, the ...
March 13, 2014
November 1, 2013 — A clinical trial designed to measure the effectiveness of using a dedicated side branch-covering bare ...
November 01, 2013
November 1, 2013 — A clinical trial comparing the use of drug-eluting stents (DES) and drug-eluting balloons (DEB) in ...
November 01, 2013
Feature | Kamran Zamanian, Ph.D.
The interventional cardiology market includes, but is not limited to, drug-eluting stents, bare-metal stents ...
February 04, 2013
December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United ...
December 27, 2012
December 7, 2012 — Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug ...
December 07, 2012© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now